Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review

JW Fjalstad, E Esaiassen, LK Juvet… - Journal of …, 2018 - academic.oup.com
Objectives To systematically review the impact of antibiotic therapy in the neonatal period on
changes in the gut microbiota and/or antibiotic resistance development. Methods Data …

How can the microbiologist help in diagnosing neonatal sepsis?

M Paolucci, MP Landini… - International journal of …, 2012 - Wiley Online Library
Neonatal sepsis can be classified into two subtypes depending upon whether the onset of
symptoms is before 72 hours of life (early‐onset neonatal sepsis—EONS) or later (late …

Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU

MH Tsai, SM Chu, JF Hsu, R Lien, HR Huang… - …, 2014 - publications.aap.org
OBJECTIVES: To assess the risk factors antibiotic therapy and outcomes of multidrug-
resistant (MDR) Gram-negative bacilli (GNB) bacteremia in NICU patients. METHODS …

Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship

SJ Patel, L Saiman - Clinics in perinatology, 2010 - perinatology.theclinics.com
Antibiotic resistance is a public health crisis. The Institute of Medicine 1 has listed control
and reduction of infections caused by antibiotic-resistant pathogens in acute care settings as …

The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum β-lactamase-producing Enterobacteriaceae …

LA Denkel, F Schwab, A Kola, R Leistner… - Journal of …, 2014 - academic.oup.com
Objectives This study aimed to determine the prevalence of and risk factors for colonization
with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and …

Bloodstream infections: epidemiology and resistance

JB Cantey, AM Milstone - Clinics in perinatology, 2015 - perinatology.theclinics.com
Bloodstream infections (BSI) are a common cause of morbidity and mortality in neonatal
intensive care units (NICUs) worldwide. Table 1 highlights the adverse outcomes associated …

Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients

D Gijón, T Curiao, F Baquero, TM Coque… - Journal of clinical …, 2012 - Am Soc Microbiol
Fecal carriage of carbapenemase-producing Enterobacteriaceae (CPE) has not been
extensively investigated, except in the cases of selected patients at risk, mostly during …

The increasing challenge of multidrug-resistant gram-negative bacilli: results of a 5-year active surveillance program in a neonatal intensive care unit

M Giuffrè, DM Geraci, C Bonura, L Saporito… - Medicine, 2016 - journals.lww.com
The Increasing Challenge of Multidrug-Resistant Gram-Negativ... : Medicine The Increasing
Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active …

[HTML][HTML] Sulbactam-containing β-lactamase inhibitor combinations

M Akova - Clinical Microbiology and Infection, 2008 - Elsevier
Sulbactam irreversibly inhibits the hydrolytic activity of β-lactamases. This compound is
commercially available in combination with either ampicillin or cefoperazone. In each …

Prevention of nosocomial infections and surveillance of emerging resistances in NICU

D Cipolla, M Giuffrè, C Mammina… - The Journal of Maternal …, 2011 - Taylor & Francis
Neonates hospitalized in NICU are at risk for healthcare associated infections because of
their poor immune defenses, related to gestational age, colonization of mucous membranes …